BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kim S, Sun JH, Kim H, Kim HK, Yang Y, Lee JS, Choi IA, Han HS. Pembrolizumab-induced psoriatic arthritis treated with disease-modifying anti-rheumatic drugs in a patient with gastric cancer: A case report. World J Clin Cases 2023; 11(1): 218-224 [PMID: 36687173 DOI: 10.12998/wjcc.v11.i1.218]
URL: https://www.wjgnet.com/2307-8960/full/v11/i1/218.htm
Number Citing Articles
1
Multiple drugsReactions Weekly 2023; 1946(1): 402 doi: 10.1007/s40278-023-35003-y
2
Yao-Tsung Yeh, Tsen-Fang Tsai. Drug- or Vaccine-Induced/Aggravated Psoriatic Arthritis: A Systematic ReviewDermatology and Therapy 2024; 14(1): 59 doi: 10.1007/s13555-023-01082-z
3
Francesca Ambrogio, Luca Rubino, Carmelo Laface, Gerardo Cazzato, Caterina Foti. Pembrolizumab-Induced Rupioid Psoriasis Treated by Apremilast Without Interrupting the Ongoing Antineoplastic TreatmentCureus 2024;  doi: 10.7759/cureus.55249